114 related articles for article (PubMed ID: 11175430)
1. (+)-N-Allylnormetazocine (NANM)-like discriminative stimulus effects of N-methyl-D-aspartate (NMDA) antagonists.
Willetts J; Rice A; Balster RL
Behav Pharmacol; 1990; 1(5):453-458. PubMed ID: 11175430
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological specificity of the discriminative stimulus properties of 2-amino-4,5-(1,2-cyclohexyl)-7-phosphono-heptanoic acid (NPC 12626), a competitive N-methyl-D-aspartate receptor antagonist.
Bobelis DJ; Balster RL
J Pharmacol Exp Ther; 1993 Feb; 264(2):845-53. PubMed ID: 8437128
[TBL] [Abstract][Full Text] [Related]
3. Pentobarbital-like discriminative stimulus effects of N-methyl-D-aspartate antagonists.
Willetts J; Balster RL
J Pharmacol Exp Ther; 1989 May; 249(2):438-43. PubMed ID: 2542531
[TBL] [Abstract][Full Text] [Related]
4. Effects of competitive and noncompetitive N-methyl-D-aspartate (NMDA) antagonists in rats trained to discriminate NMDA from saline.
Willetts J; Balster RL
J Pharmacol Exp Ther; 1989 Nov; 251(2):627-33. PubMed ID: 2553930
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the reinforcing and discriminative stimulus effects of the N-methyl-D-aspartate competitive antagonist NPC 17742 in rhesus monkeys.
Nicholson KL; Jones HE; Balster RL
Behav Pharmacol; 1997 Oct; 8(5):396-407. PubMed ID: 9832979
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the reinforcing and discriminative stimulus properties of the low-affinity N-methyl-D-aspartate channel blocker memantine.
Nicholson KL; Jones HE; Balster RL
Behav Pharmacol; 1998 May; 9(3):231-43. PubMed ID: 9832937
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the discriminative stimulus effects of N-methyl- D-aspartate ligands under different ethanol training conditions in the cynomolgus monkey ( Macaca fascicularis).
Vivian JA; Waters CA; Szeliga KT; Jordan K; Grant KA
Psychopharmacology (Berl); 2002 Jul; 162(3):273-81. PubMed ID: 12122485
[TBL] [Abstract][Full Text] [Related]
8. Ethanol-like discriminative stimulus effects of non-competitive n-methyl-d-aspartate antagonists.
Grant KA; Knisely JS; Tabakoff B; Barrett JE; Balster RL
Behav Pharmacol; 1991 Apr; 2(2):87-95. PubMed ID: 11224052
[TBL] [Abstract][Full Text] [Related]
9. Behavioral pharmacology of NPC 17742, a competitive N-methyl-D-aspartate (NMDA) antagonist.
Willetts J; Clissold DB; Hartman TL; Brandsgaard RR; Hamilton GS; Ferkany JW
J Pharmacol Exp Ther; 1993 Jun; 265(3):1055-62. PubMed ID: 8099615
[TBL] [Abstract][Full Text] [Related]
10. N-methyl-D-aspartate antagonism and phencyclidine-like activity: a drug discrimination analysis.
Koek W; Woods JH; Colpaert FC
J Pharmacol Exp Ther; 1990 Jun; 253(3):1017-25. PubMed ID: 2193142
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological evaluation of N-allynormetazocine (SKF 10,047) on the basis of its discriminative stimulus properties in the rat.
Shannon HE
J Pharmacol Exp Ther; 1983 Apr; 225(1):144-52. PubMed ID: 6834266
[TBL] [Abstract][Full Text] [Related]
12. Substitution and antagonism in rats trained to discriminate (+)-N-allylnormetazocine from saline.
Balster RL
J Pharmacol Exp Ther; 1989 Jun; 249(3):749-56. PubMed ID: 2471825
[TBL] [Abstract][Full Text] [Related]
13. Effects of phencyclidine and other N-methyl-D-aspartate antagonists on the schedule-controlled behavior of rats.
Sanger DJ; Jackson A
J Pharmacol Exp Ther; 1989 Mar; 248(3):1215-21. PubMed ID: 2649656
[TBL] [Abstract][Full Text] [Related]
14. Substitution for PCP, disruption of prepulse inhibition and hyperactivity induced by N-methyl-D-aspartate receptor antagonists: preferential involvement of the NR2B rather than NR2A subunit.
Chaperon F; Müller W; Auberson YP; Tricklebank MD; Neijt HC
Behav Pharmacol; 2003 Sep; 14(5-6):477-87. PubMed ID: 14501261
[TBL] [Abstract][Full Text] [Related]
15. Behavioral pharmacology of two novel substituted quinoxalinedione glutamate antagonists.
Balster RL; Mansbach RS; Shelton KL; Nicholson KL; Grech DM; Wiley JL; Li H; Weber E
Behav Pharmacol; 1995 Aug; 6(5 And 6):577-589. PubMed ID: 11224365
[TBL] [Abstract][Full Text] [Related]
16. Discriminative stimulus properties of (+)- and (-)-n allylnormetazocine: the role of training dose in the stimulus substitution patterns produced by PCP/sigma and mixed action opioid compounds.
Picker MJ
Behav Pharmacol; 1991 Dec; 2(6):497-511. PubMed ID: 11224092
[TBL] [Abstract][Full Text] [Related]
17. MK-801 and related compounds in monkeys: discriminative stimulus effects and effects on a conditional discrimination.
France CP; Moerschbaecher JM; Woods JH
J Pharmacol Exp Ther; 1991 May; 257(2):727-34. PubMed ID: 2033515
[TBL] [Abstract][Full Text] [Related]
18. The discriminative stimulus effects of MK-801 in pigeons.
Butelman ER; France CP; Woods JH
Behav Pharmacol; 1991 Apr; 2(2):79-86. PubMed ID: 11224051
[TBL] [Abstract][Full Text] [Related]
19. Discriminative stimulus effects of ethanol: effect of training dose on the substitution of N-methyl-D-aspartate antagonists.
Grant KA; Colombo G
J Pharmacol Exp Ther; 1993 Mar; 264(3):1241-7. PubMed ID: 8450461
[TBL] [Abstract][Full Text] [Related]
20. Is the discriminative stimulus produced by phencyclidine due to an interaction with N-methyl-D-aspartate receptors?
Jackson A; Sanger DJ
Psychopharmacology (Berl); 1988; 96(1):87-92. PubMed ID: 2906445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
